{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:04:37Z","timestamp":1784556277684,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11892-006-0060-5","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T10:37:21Z","timestamp":1180694241000},"page":"274-278","source":"Crossref","is-referenced-by-count":37,"title":["Inhibition of the renin angiotensin system: Implications for the endothelium"],"prefix":"10.1007","volume":"6","author":[{"given":"Carmine","family":"Savoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto L.","family":"Schiffrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"H435","DOI":"10.1152\/ajpheart.00262.2004","volume":"287","author":"EL Schiffrin","year":"2004","unstructured":"Schiffrin EL, Touyz RM: From bedside to bench to bedside: role of the renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004, 287:H435-H446.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"60_CR2","first-page":"152","volume":"15","author":"C Savoia","year":"2006","unstructured":"Savoia C, Schiffrin EL: Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006, 15:152\u2013158.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00041552-200503000-00007","volume":"14","author":"R Touyz","year":"2005","unstructured":"Touyz R: Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005, 14:125\u2013131.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1050-1738(98)00022-X","volume":"8","author":"RD Feldman","year":"1988","unstructured":"Feldman RD, Gros R: Impaired vasodilator function in hypertension. The role of alterations in receptor-G protein coupling. Trends Cardiovasc Med 1988, 8:297\u2013305.","journal-title":"Trends Cardiovasc Med"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.21.5.729","volume":"21","author":"K Lamping","year":"2001","unstructured":"Lamping K: Interactions between NO and cAMP in the regulation of vascular tone. Arterioscler Thromb Vasc Biol 2001, 21:729\u2013730.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004872-200103000-00009","volume":"19","author":"JB Park","year":"2001","unstructured":"Park JB, Schiffrin EL: Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens 2001, 19:415\u2013420.","journal-title":"J Hypertens"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bjp.0706042","volume":"144","author":"PM Vanhoutte","year":"2005","unstructured":"Vanhoutte PM, Feletou M, Taddei S: Endothelium dependent contraction in hypertension. Br J Pharmacol 2005, 144:449\u2013458.","journal-title":"Br J Pharmacol"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"H445","DOI":"10.1152\/ajpheart.1990.258.2.H445","volume":"258","author":"DA Diedrich","year":"1990","unstructured":"Diedrich DA, Yang Z, Bulher FR, Luscher TF: Impaired endothelium-dependent relaxation in hypertensive resistance arteries involves the cyclooxygenase pathway. Am J Physiol Heart Circ Physiol 1990, 258:H445-H451.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"II61","DOI":"10.1161\/01.HYP.8.6_Pt_2.II61","volume":"8","author":"W Luckette","year":"1986","unstructured":"Luckette W, Otsuka Y, Carretero O: The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986, 8:II61-II66.","journal-title":"Hypertension"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai H, Harrison DG: Endothelial dysfunction in cardiovascular disease. The role of oxidant stress. Circ Res 2000, 87:840\u2013844.","journal-title":"Circ Res"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","volume":"111","author":"U Landmesser","year":"2003","unstructured":"Landmesser U, Dikalov S, Price SR, et al.: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111:1201\u20131209.","journal-title":"J Clin Invest"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00418-004-0696-7","volume":"122","author":"RM Touyz","year":"2004","unstructured":"Touyz RM, Schiffrin EL: Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004, 122:339\u2013352. A complete update on the role of ROS in cardiovascular pathology.","journal-title":"Histochem Cell Biol"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","volume":"285","author":"B Lassegue","year":"2003","unstructured":"Lassegue B, Clempus RE: Vascular NAD(P)H oxidase: specific features, expression and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R277-R297.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1074\/jbc.M209793200","volume":"278","author":"JM Li","year":"2003","unstructured":"Li JM, Shah AM: Mechanism of endothelial cell NAD(P)H oxidase activation by angiotensin II. Role of p47phox subunit. J Biol Chem 2003, 278:12094\u201312100.","journal-title":"J Biol Chem"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"14483","DOI":"10.1073\/pnas.94.26.14483","volume":"94","author":"PJ Pagano","year":"1997","unstructured":"Pagano PJ, Clark JK, Cifuentes-Pagano ME, et al.: Localization of a constitutive active, phagocyte-like NAD(P)H oxidase in rabbit aortic adventitia. Enhancement by angiotensin II. Proc Natl Acad Sci U S A 1997, 94:14483\u201314488.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.80.1.45","volume":"80","author":"T Fukui","year":"1997","unstructured":"Fukui T, Ishizaka N, Rajagopalan S, et al.: p22phox mRNA expression and NAD(P)H oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997, 80:45\u201351.","journal-title":"Circ Res"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/00004872-199917070-00006","volume":"17","author":"RM Touyz","year":"1999","unstructured":"Touyz RM, Deng LY, He G, et al.: Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens 1999, 17:907\u2013916.","journal-title":"J Hypertens"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.ATV.0000069236.27911.68","volume":"23","author":"RM Touyz","year":"2003","unstructured":"Touyz RM, Yao G, Schiffrin EL: c-Src induces phosphorylation and translocation of p47phox. Role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003, 23:981\u2013987.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2005.03.004","volume":"43","author":"EL Schiffrin","year":"2005","unstructured":"Schiffrin EL: Vascular endothelin in hypertension. Vasc Pharmacol 2005, 43:19\u201329. A recent and comprehensive review on the role of the endothelin system in cardiovascular pathology.","journal-title":"Vasc Pharmacol"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cardiores.2003.10.019","volume":"61","author":"HJ Hong","year":"2004","unstructured":"Hong HJ, Chan P, Liu JC, et al.: Angiotensin II induces endothelin-1 gene expression via extracellular signalregulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004, 61:159\u2013168.","journal-title":"Cardiovasc Res"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","volume":"42","author":"Q Pu","year":"2003","unstructured":"Pu Q, Neves MF, Virdis A, et al.: Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 2003, 42:49\u201355.","journal-title":"Hypertension"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1006\/jmcc.2000.1178","volume":"32","author":"J Kahler","year":"2000","unstructured":"Kahler J, Mendel S, Weckmuller J, et al.: Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 2000, 32:1429\u20131437.","journal-title":"J Mol Cell Cardiol"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005344-200107000-00006","volume":"38","author":"J Kahler","year":"2001","unstructured":"Kahler J, Ewert A, Weckmuller J, et al.: Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol 2001, 38:49\u201357.","journal-title":"J Cardiovasc Pharmacol"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.CIR.0000051459.74466.46","volume":"107","author":"LX Li","year":"2003","unstructured":"Li LX, Fink GD, Watts SW, et al.: Endothelin-1 increases vascular superoxide via endothelin A-NAD(P)H oxidase pathway in low renin hypertension. Circulation 2003, 107:1053\u20131058.","journal-title":"Circulation"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.ATV.0000047447.67827.CD","volume":"23","author":"M Iglarz","year":"2003","unstructured":"Iglarz M, Touyz RM, Amiri F, et al.: Effect of peroxisome proliferator-activated receptor-alpha and-gamma activators on vascular remodeling in endothelin-dependent hypertension. Arterioscl Thromb Vasc Biol 2003, 23:45\u201351.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000144462.08345.B9","volume":"110","author":"F Amiri","year":"2004","unstructured":"Amiri F, Virdis A, Neves MF, et al.: Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004, 110:2233\u20132240.","journal-title":"Circulation"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00004872-200406000-00015","volume":"22","author":"RM Touz","year":"2004","unstructured":"Touz RM, Yao G, Viel E, et al.: Angiotensin II and endothelin-1 regulate MAP kinases through different redoxdependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004, 22:1141\u20131149.","journal-title":"J Hypertens"},{"key":"60_CR28","first-page":"L1058","volume":"281","author":"S Wedgwood","year":"2001","unstructured":"Wedgwood S, Dettman RW, Black SM, et al.: ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol 2001, 281:L1058-L1067.","journal-title":"Am J Physiol"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.HYP.30.1.29","volume":"30","author":"S Rajagopalan","year":"1997","unstructured":"Rajagopalan S, Laursen JB, Borthayre A, et al.: Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension 1997, 30:29\u201334.","journal-title":"Hypertension"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/00004872-200312000-00010","volume":"21","author":"EL Schiffrin","year":"2003","unstructured":"Schiffrin EL: The angiotensin-endothelin relationship: does it play a role in cardiovascular and renal pathophysiology? J Hypertens 2003, 21:2245\u20132247.","journal-title":"J Hypertens"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","volume":"104","author":"E Harada","year":"2001","unstructured":"Harada E, Yoshimura M, Yasue H, et al.: Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 2001, 104:137\u2013139.","journal-title":"Circulation"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"H608","DOI":"10.1152\/ajpheart.1984.246.4.H608","volume":"246","author":"EL Schiffrin","year":"1984","unstructured":"Schiffrin EL, Gutkowska J, Genest J: Effect of angiotensin II on deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am J Physiol Heart Circ Physiol 1984, 246:H608-H614.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","volume":"47","author":"EL Schiffrin","year":"2006","unstructured":"Schiffrin EL: Effects of aldosterone on the vasculature. Hypertension 2006, 47:312\u2013318. A comprehensive and updated review on the effects of aldosterone on the cardiovascular system in several experimental models and in humans.","journal-title":"Hypertension"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","volume":"110","author":"A Garnier","year":"2004","unstructured":"Garnier A, Bendall JK, Fuchs S, et al.: Cardiac-specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase transgenic mice. Circulation 2004, 110:1819\u20131825.","journal-title":"Circulation"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","volume":"40","author":"A Virdis","year":"2002","unstructured":"Virdis A, Neves MF, Amiri F, et al.: Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002, 40:504\u2013510.","journal-title":"Hypertension"},{"key":"60_CR36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.0000171479.36880.17","volume":"46","author":"J Blanco-Rivero","year":"2005","unstructured":"Blanco-Rivero J, Cachofeiro V, Lahera V, et al.: Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 2005, 46:107\u2013112.","journal-title":"Hypertension"},{"key":"60_CR37","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1523-1755.2005.00263.x","volume":"67","author":"H Oberleithner","year":"2005","unstructured":"Oberleithner H: Aldosterone makes human endothelium stiff and vulnerable. Kidney Int 2005, 67:1680\u20131682. An intriguing new evidence on the role of aldosterone in endothelial dysfunction.","journal-title":"Kidney Int"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/hy1101.092970","volume":"38","author":"EJ Henriksen","year":"2001","unstructured":"Henriksen EJ: Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001, 38:884\u2013890.","journal-title":"Hypertension"},{"key":"60_CR39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.HYP.0000111136.86976.26","volume":"43","author":"K Shinozaki","year":"2004","unstructured":"Shinozaki K, Ayajiki K, Nishio Y, et al.: Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004, 43:255\u2013262.","journal-title":"Hypertension"},{"key":"60_CR40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/01.HYP.16.5.532","volume":"16","author":"M Clozel","year":"1990","unstructured":"Clozel M, Kuhn H, Hefti F: Effects of angiotensin converting enzyme inhibitors and hydralazine on endothelial function in hypertensive rats. Hypertension 1990, 16:532\u2013540.","journal-title":"Hypertension"},{"key":"60_CR41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00004872-199816040-00007","volume":"16","author":"AM Shari","year":"1998","unstructured":"Shari AM, Li JF, Endemann D, Schiffrin EL: Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 1998, 16:457\u2013466.","journal-title":"J Hypertens"},{"key":"60_CR42","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/01.CIR.96.7.2407","volume":"96","author":"H Hayakawa","year":"1997","unstructured":"Hayakawa H, Coffee K, Raij L: Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effect of antihypertensive therapy. Circulation 1997, 96:2407\u20132413.","journal-title":"Circulation"},{"key":"60_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.HYP.23.1.83","volume":"23","author":"EL Schiffrin","year":"1994","unstructured":"Schiffrin EL, Deng LY, Larochelle P: Effect of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994, 23:83\u201391.","journal-title":"Hypertension"},{"key":"60_CR44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0895-7061(95)96211-2","volume":"8","author":"EL Schiffrin","year":"1995","unstructured":"Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor: comparison with effects of a beta-blocker. Am J Hypertens 1995, 8:229\u2013236.","journal-title":"Am J Hypertens"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.25.4.699","volume":"25","author":"EL Schiffrin","year":"1995","unstructured":"Schiffrin EL, Deng LY: Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995, 25:699\u2013703.","journal-title":"Hypertension"},{"key":"60_CR46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.HYP.25.4.474","volume":"25","author":"NK Thybo","year":"1995","unstructured":"Thybo NK, Stephens N, Cooper A, et al.: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995, 25(Pt 1):474\u2013481.","journal-title":"Hypertension"},{"key":"60_CR47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004872-199715020-00011","volume":"15","author":"D Rizzoni","year":"1997","unstructured":"Rizzoni D, Muiesan ML, Porteri E, et al.: Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997, 15:197\u2013204.","journal-title":"J Hypertens"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1161\/01.CIR.94.12.3115","volume":"94","author":"I Antony","year":"1996","unstructured":"Antony I, Lerebours G, Nitemberg A: Angiotensin converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation 1996, 94:3115\u20133122.","journal-title":"Circulation"},{"key":"60_CR49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00004872-199816040-00006","volume":"16","author":"S Taddei","year":"1998","unstructured":"Taddei S, Virdis A, Ghiadoni L, et al.: Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J Hypertens 1998, 16:447\u2013456.","journal-title":"J Hypertens"},{"key":"60_CR50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.HYP.0000153308.91043.97","volume":"45","author":"D Rizzoni","year":"2005","unstructured":"Rizzoni D, Porteri E, De Ciuceis C, et al.: Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. Hypertension 2005, 45:659\u2013665.","journal-title":"Hypertension"},{"key":"60_CR51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjhyper.2004.11.007","volume":"18","author":"F Cosentino","year":"2005","unstructured":"Cosentino F, Savoia C, De Paolis P, et al.: Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens 2005, 18(4 Pt 1):493\u2013499.","journal-title":"Am J Hypertens"},{"key":"60_CR52","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.HYP.0000153305.50128.a1","volume":"45","author":"RA Malik","year":"2005","unstructured":"Malik RA, Schofield IJ, Izzard A, et al.: Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. Hypertension 2005, 45:264\u2013269.","journal-title":"Hypertension"},{"key":"60_CR53","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","volume":"101","author":"EL Schiffrin","year":"2000","unstructured":"Schiffrin EL, Park JB, Intengam HD, Touyz RM: Correction of arterial structure and endothelial dysfunction in humans essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000, 101:1653\u20131659.","journal-title":"Circulation"},{"key":"60_CR54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004872-200201000-00011","volume":"20","author":"EL Schiffrin","year":"2002","unstructured":"Schiffrin EL, Park JB, Pu Q: Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and endothelial function. J Hypertens 2002, 20:71\u201378.","journal-title":"J Hypertens"},{"key":"60_CR55","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","volume":"276","author":"H Lother","year":"2001","unstructured":"Lother H, Abdel-tawab AM, Quitterer U: The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001, 276:39721\u201339726.","journal-title":"J Biol Chem"},{"key":"60_CR56","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","volume":"26","author":"UM Steckelings","year":"2005","unstructured":"Steckelings UM, Kaschina E, Unger T: The AT2 receptor. A matter of love or hate. Peptides 2005, 26:1401\u20131409.","journal-title":"Peptides"},{"key":"60_CR57","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","volume":"109","author":"S Keidar","year":"2004","unstructured":"Keidar S, Kaplam M, Pavlotzky E, et al.: Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 2004, 109:2213\u20132220.","journal-title":"Circulation"},{"key":"60_CR58","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","volume":"46","author":"S Takai","year":"2005","unstructured":"Takai S, Jin D, Muramatsu M, et al.: Eplerenone inhibits atherosclerosis in nonhuman primates. Hypertension 2005, 46:1135\u20131139.","journal-title":"Hypertension"},{"key":"60_CR59","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","volume":"40","author":"QN Diep","year":"2002","unstructured":"Diep QN, Amiri F, Touyz R, et al.: PPAR alpha activator effects on Ang II-induced vascular oxidative stress and Inflammation. Hypertension 2002, 40:866\u2013871.","journal-title":"Hypertension"},{"key":"60_CR60","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000016049.86468.23","volume":"105","author":"QN Diep","year":"2002","unstructured":"Diep QN, El Mabrouk M, Cohn JS, et al.: Structure, endothelial function, cell growth, and Inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation 2002, 105:2296\u20132302.","journal-title":"Circulation"},{"key":"60_CR61","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.HYP.0000084370.74777.B6","volume":"42","author":"EL Schiffrin","year":"2003","unstructured":"Schiffrin EL, Amiri F, Benkirane K, et al.: Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. Hypertension 2003, 42:664\u2013668.","journal-title":"Hypertension"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-006-0060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-006-0060-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-006-0060-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:16Z","timestamp":1559433376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-006-0060-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11892-006-0060-5","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}